Suppr超能文献

浆细胞病中肾小球滤过率的评估——门诊实践采用哪种检测方法?

[Evaluation of glomerular filtration rate in plasma cell dyscrasias--which test for ambulatory practice?].

作者信息

Zelichowski G, Raczka A, Wańkowicz Z

机构信息

Klinika Nefrologii ze Stacja Dializ Centralnego Szpitala Klinicznego WAM w Warszawie.

出版信息

Pol Arch Med Wewn. 2001 Nov;106(5):1049-53.

Abstract

To select the best mathematical formula for ambulatory monitoring of glomerular filtration rate (GFR) in patients with plasma cell dyscrasias (PCD's) we evaluated GFR in 32 pts (22 M + 10 F; mean age 66.1 +/- 9.6) with newly recognized PCD's with the following routine GFR tests: creatinine concentration in serum (Crs); 24 hr's standard creatinine clearance (Crcl) as a reference test; calculation of GFR from Baracskay (BGFR) and Cockcroft-Gault (C-GGFR) formulas. There were: 16 pts without monoclonal proteinuria MP(-) and 16 pts with monoclonal proteinuria MP(+) (0.44-40.3; mean 9.54 g/day). The abnormal values for Crs were defined as > 1.5 mg/dl; for Crcl as < 80.0 ml/min. Only 41% (13/32) of pts had abnormal values of Crs and 84% (27/32) had abnormal values of Crcl. In the group of pts without monoclonal proteinuria MP(-) statistical significance between 24-hr's creatinine clearance and GFR calculated by Cockcroft-Gault as well as Baracskay formulas was not stated. In the group of pts with monoclonal proteinuria MP(+) statistical significance was not stated only between 24-hr's creatinine clearance and GFR calculated by Cockcroft-Gault formula. That was no statistical significance in GFR evaluated with this methods between patients with kappa and lambda monoclonal proteinuria. We concluded, that for ambulatory monitoring of pts with PCD's MP(+) only Cockcroft-Gault formula is recommended. On the other hand pts MP(-) might be monitored using Barasckay as well as Cockcroft-Gault formulas. Because Csr over estimated values of Crcl in both groups of pts, the other serum marker of GFR should be investigated.

摘要

为了选择用于浆细胞病(PCD)患者肾小球滤过率(GFR)动态监测的最佳数学公式,我们采用以下常规GFR检测方法对32例新确诊的PCD患者(22例男性+10例女性;平均年龄66.1±9.6岁)的GFR进行了评估:血清肌酐浓度(Crs);24小时标准肌酐清除率(Crcl)作为参考检测;根据巴拉茨凯公式(BGFR)和考克洛夫特-高尔特公式(C-GGFR)计算GFR。其中:16例无单克隆蛋白尿患者MP(-)和16例有单克隆蛋白尿患者MP(+)(0.44 - 40.3;平均9.54g/天)。Crs异常值定义为>1.5mg/dl;Crcl异常值定义为<80.0ml/min。仅41%(13/32)的患者Crs值异常,84%(27/32)的患者Crcl值异常。在无单克隆蛋白尿患者组MP(-)中,24小时肌酐清除率与考克洛夫特-高尔特公式以及巴拉茨凯公式计算的GFR之间未显示统计学意义。在有单克隆蛋白尿患者组MP(+)中,仅24小时肌酐清除率与考克洛夫特-高尔特公式计算的GFR之间未显示统计学意义。在kappa和lambda单克隆蛋白尿患者中,用这些方法评估的GFR之间无统计学意义。我们得出结论,对于PCD患者MP(+)的动态监测,仅推荐考克洛夫特-高尔特公式。另一方面,可以使用巴拉茨凯公式以及考克洛夫特-高尔特公式对MP(-)患者进行监测。由于两组患者中Csr均高估了Crcl值,因此应研究其他GFR血清标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验